During the Great Ritalin Scare of 1993, shortages prompted thousands to switch to Adderall. Now, Shire is contriving an Adderall drought to convert patients to a new ADD drug.
Much like the historical practice of using Mercury to treat syphilis, GlaxoSmithKline's diet drug Orlistat could be an effective solution for the present but a dangerous precedent for the future.
